Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets
Status:
Completed
Trial end date:
2023-04-06
Target enrollment:
Participant gender:
Summary
Single dose oral bioequivalence study of Riociguat 2.5 mg film coated tablets and 'Adempas'
(Riociguat) 2.5 mg Filmtabletten (film coated tablets) in healthy adult male subjects under
fasting conditions.